Independent information services
Wide Anchor 33 offers guides, comparisons, research summaries, and decision frameworks for San Francisco residents seeking a clear view of ibogaine claims, legal realities, safety concerns, and established treatment options.
Explore treatment reality
What is available here
These are informational offerings, not clinical services. They are designed to help readers separate what is known, what remains uncertain, and what questions matter before acting on treatment claims.
Plain-language guides explain why ibogaine is discussed, what is claimed, and why investigational interest should not be confused with established treatment. The San Francisco ibogaine overview provides a starting point for the wider context.
Treatment realityComparison pages place ibogaine alongside established substance-use care, with attention to evidence, supervision, legal status, and risk. For background on how this resource approaches those distinctions, see our purpose and methods.
Compare optionsResearch summaries distinguish early findings from clinical proof and note the limits of small, selective, or uncontrolled evidence. The National Institute on Drug Abuse overview of medications for opioid use disorder describes established medication options in this area.
Review safety contextFAQ-style explanations define common terms and identify questions families may encounter when evaluating an unregulated offering. Readers exploring claims involving neurologic conditions can also review the independent context collected at ibogaine treatment for Parkinson’s.
Contact scopeA useful distinction
Ibogaine is a psychoactive substance associated with the iboga plant. Its history and use are described in the Ibogaine reference overview, but a definition alone does not establish safety or effectiveness for a particular person.
How the resource frames risk
Wide Anchor 33 does not diagnose, recommend, or arrange treatment. It organizes questions that can otherwise be obscured by marketing language, particularly where a substance is discussed outside established local care.
For federal context, the DEA explanation of drug scheduling outlines the U.S. scheduling framework that shapes legal realities around controlled substances.
“The useful question is not whether a claim sounds promising. It is what evidence supports it, what risks remain, and what established care is available now.”
Start with context
Begin with the treatment reality guide, then use the safety and comparison pages to place ibogaine discussions beside the information needed for an informed choice.
Read the treatment reality guide